Regulatory Story
Go to market news section View chart   Print
RNS

Interim results to 31 March 2019

Released 07:00 05-Jun-2019

RNS Number : 1461B
Impax Asset Management Group plc
05 June 2019
 

Impax Asset Management Group plc

Interim results to 31 March 2019

 

 

London, 5 June 2019 - Impax Asset Management Group plc ('Impax' or the 'Company'), the specialist investor focused on a more sustainable global economy, today announces interim results for the six months to 31 March 2019 (the 'Period').

 

Ian Simm, Chief Executive commented:

"I am pleased to report that despite volatile market conditions Impax has delivered strong results, with assets under management expanding 6% to £13.3 billion by the end of the first half of our financial year on 31 March 2019, and further to £13.7 billion by 30 April 2019."

"Developed over two decades, Impax's specialist expertise as investors in the transition to a more sustainable economy is resonating with a range of asset owners around the world, and the Company remains well placed for further growth." 

 

H1 business highlights

 

·      Despite volatile markets AUM over the Period increased 6%

·      Positive net inflows for 14 consecutive quarters

·      Strong organic growth with £887 million of net inflows

·      Robust investment performance, particularly the 'Global Opportunities' strategy

 

H1 financial highlights

 

·      Revenue £33.8 million (H1 2018 £25.7m)

·      Adjusted operating profit £7.7 million (H1 2018 £7.7m)

·      Profit before tax £9.3 million (H1 2018 £5.5m)

·      Adjusted diluted earnings per share 4.4 pence (H1 2018 4.8p)

·      Interim dividend 1.5 pence (H1 2018 1.1p)

·      Shareholder's equity £54.6 million (H1 2018 £46.9m)

 

 

The presentation for shareholders and analysts will be available to view on the Company's website later this morning: https://www.impaxam.com/investor-relations/reports-and-presentations 

 

 

LEI number: 213800AJDNW4S2B7E680

 

 

Enquiries:

 

Karen Wagg, Director of Communications

Impax Asset Management Group plc

 

k.wagg@impaxam.com

+44 (0) 20 3912 3142

Ian Simm, Chief Executive

Impax Asset Management Group plc

 

 

+44 (0) 20 3912 3000

Gay Collins / Louis Supple

Montfort Communications

impax@montfort.london

+44 (0) 77 98 62 62 82 / +44 (0) 20 3770 7914

 

Guy Wiehahn / Rishi Shah, Nominated Adviser

Peel Hunt LLP

+44 (0) 20 7418 8900

 

CHIEF EXECUTIVE'S REPORT

 

I am pleased to report that, despite volatile market conditions, Impax Asset Management Group plc ('Impax' or the 'Company') has delivered strong results for the six months to 31 March 2019 (the 'Period'), reflecting rising demand among asset owners for exposure to companies leading the transition to a more sustainable economy. During the Period global equity markets initially fell as investors were troubled by geopolitical uncertainty, the impact of tightening monetary policies, an escalating trade war between China and the USA and Brexit. At the start of calendar 2019, sentiment recovered strongly, and markets bounced. At Period end the Company's assets under management and advice ('AUM') were £13.3 billion, representing an increase of 20% in the 12 months since 31 March 2018 and 6% over the Period. As of 30 April 2019, the Company's AUM has risen further to £13.7 billion.

 

MARKET DEVELOPMENTS

 

The transition to a more sustainable global economy is set to create enormous economic benefits and momentum is building. Impax has been investing in this transition for more than two decades and we continue to see many compelling new long-term investment opportunities, with rising interest from a wide range of asset owners around the world.

 

Although historically regulations have typically shaped demand in environmental markets, consumer interest is now an important contributor. For example, as the 'war on plastics' continues to gather pace, companies in the areas of recycling, reverse vending and alternative packaging are reporting strong prospects. In the food sector, many consumers in developed countries are moving away from established brands and favouring natural foods and lower levels of meat consumption. In the transport sector we have observed a new wave of investment in electric vehicle (EVs) manufacturing and supporting infrastructure, such as the Mayor of London's plan to invest £24m to help black cab drivers switch to EVs.

 

INVESTMENT PERFORMANCE

 

During the Period our London-managed listed equity strategies generally out-performed their generic benchmarks, typically the MSCI All Country World Index ('ACWI'). Our 'Global Opportunities' strategy, a broad-based global equity portfolio, which is now in its fifth year, was again the best-performing strategy.

Performance of the Pax World Funds was mixed, with the actively managed funds moderately ahead of benchmark and the fixed income funds slightly behind.

 

REAL ASSETS

 

The sale of the remaining assets of our second renewable energy infrastructure fund, Impax New Energy Investors II ('NEF II') is nearly complete and we expect to return all outstanding proceeds to investors over the next eighteen months. Our third fund, Impax New Energy Investors III ('NEF III') is continuing to make investments across Europe. These have included a large acquisition in France and a portfolio of hydropower assets in Norway. During the 2019 calendar year we expect to invest at least €100 million of the fund's capital.

 

FUND FLOWS AND DISTRIBUTION

 

Overall, we welcomed £887 million of net inflows from clients during the Period. Interest in our London managed strategies has remained strong. In addition to attracting material flows into the collective funds that we manage, sub-manage or advise, we also launched three new segregated accounts for institutional investors and we expect to launch a number of significant new accounts before the end of the calendar year. Although in aggregate the Pax World Funds experienced net outflows, there were net inflows into more differentiated products, particularly the Global Women's Leadership Fund. Looking ahead to 2020, as several of these funds reach their three- year track record, we expect investor interest to pick up.

AUM movement 12 months
to 30 September 2018

Impax Asset Management Ltd
Impax Asset Management AIFM Ltd
(Impax LN)

Impax Asset Management LLC
(Impax NH)

Reconcilliation2
£m

Total firm
£m

Thematic
equity funds
£m

Real
asset funds
1
£m

Fixed income,
smart beta, US equity funds
£m

Total AUM at 30 September 2018

9,024

3,644

(603)

12,515

Net flows

1,103

(216)

-

887

Market movement, FX and performance

(67)

(74)

6

(149)

Total AUM at 31 March 2019

10,060

436

3,354

(596)

13,253

                                      

1 Real Assets comprise Private Equity and Property funds

2 Avoidance of double count of Pax Global Environmental Markets Fund and Pax Global Opportunities Fund

 

FINANCIAL RESULTS FOR THE PERIOD

 

Revenue for the six months to 31 March 2019 was £33.8 million (H1 2018 £25.7 million, H2 2018 £40 million including £6.1 million of one-off private equity income). Excluding the one-off income in H2, Impax LN (the business excluding the Pax World Management business that we bought in January 2018) grew revenue by £1.0 million, thanks to continued strong inflows. Revenue from Impax NH (the Pax World Management business) fell by £0.9 million from H2 2018, reflecting outflows in a very weak US mutual fund market. The Company's annualised run-rate revenue at the end of the Period was £72.4 million, giving a weighted average run rate revenue margin of 55 basis points on the £13.3 billion of AUM.

As previously noted, to facilitate comparison of performance with prior periods and to provide an appropriate comparison with peers, the Board encourages shareholders to focus on adjusted financial measures. For example, operating profit, profit before tax and diluted earnings per share after adjustment for non-recurring acquisition costs, accounting charges or credits arising from the acquisition accounting for Impax NH and adjustments arising from the accounting treatment of National Insurance on share awards. Reconciliations of the adjusted amounts to the IFRS amounts are shown in Note 3.

Adjusted operating costs for the period were £26.1 million (H1 2018 £18.0 million, H2 £27.7 million). Costs fell from H2 2018 due to the absence of costs associated with the one-off private equity income, but this was in part offset by planned increases in staff and other recurring costs.

Adjusted operating profits for the period were £7.7 million (H1 2018, £7.7 million, H2 2018 £12.3m). The fall from H2 2018 was largely due to the absence of one-off private equity income. Benefits from the inflows in Impax LN were largely offset by the impact of market falls and cost increases.

At the end of the Period annualised run-rate adjusted operating profits were £18.8 million, equivalent to a run-rate operating margin of 26%.

Each reporting period we are required to estimate the contingent consideration payable on the Impax NH acquisition and any adjustment to this liability must be recorded through IFRS operating profit. Given our estimates of Impax NH growth in funds under management we have adjusted our estimate down to £nil. IFRS operating profit benefited by £3.5 million from this adjustment and increased to £9.9 million (H1 2018 £5.7 million, H2 2018 £9.7 million).

Interest expense and non-operating costs totalled £0.5 million (H1 2018 £0.3 million, H2 2018 £0.4 million) giving adjusted profit before tax of £7.2 million (H1 2018 £7.4 million, H2 2018 £11.8 million). IFRS profit before tax was £9.3 million (H1 2018, £5.5 million, H2 2018 £9.1 million). Tax rates were in line with prior periods. Adjusted diluted earnings per share for the period was 4.4 pence (H1 2018 4.8 pence, H2 2018 7.6 pence).

Impax continues to be a strongly cash generative business and paid down £3.3 million of term debt in January 2019 leaving £6.6 million outstanding. Cash reserves at the period end stood at £14.9 million and we continue to have US$13 million available to utilise under a revolving credit facility. At the period end the Company exited its successful UCITS investment based on the Global Opportunities strategy, realising £2 million.

 

DIVIDENDS

 

A final dividend for 2018 of 3.0 pence was paid in March 2019 following approval at the Annual General Meeting. This takes the total dividend paid for 2018 to 4.1 pence plus a special dividend of 2.6 pence.

The Board is declaring an interim dividend for the Period of 1.5 pence per share (2018: 1.1 pence) reflecting the encouraging development of the Group's financial resources. This will be paid on 19 July 2019 to Ordinary Shareholders on the shareholder register at the close of business on 14 June 2019.

The Company operates a dividend reinvestment plan ('DRIP'). The final date for receipt of elections under the DRIP will be 28 June 2019. For further information and to register and elect for this facility, please visit www.signalshares. com and search for information related to the Company.

 

BUSINESS OPERATIONS

 

Given the scale of Impax's future potential, we are continuing our long-term programme to build out our capabilities, while minimising the need for large, one-off investments. Over the past 12 months we have focused on strengthening our IT platform, extending our risk and compliance functions and developing further the Company's human resources function.

We have made good progress in integrating the Pax World Management business, which we acquired in early 2018. We have fully integrated or established close co-operation across most support teams, for example finance, compliance, human resources, trading and back/middle office. The client service and business development teams, which are subject to different regulations in their respective jurisdictions, are deepening their collaboration, and the investment teams are able to pool their research and analysis.

The deadline has been extended but clarity around the nature of the UK's departure from the European Union is still absent. There are a number of potential scenarios and Impax is well positioned to respond to the outcomes that could transpire. In particular, we have established an Irish entity, Impax Asset Management Ireland Limited, which is now authorised by the Central Bank of Ireland as, amongst other things, a UCITS management company pursuant to the UCITS Regulations.

 

SHARE MANAGEMENT

 

The company did not issue any new shares in the period and shares in issue stood at 130.4 million.

The Board intends to continue to buy-back the Company's shares from time to time after due consideration of alternative uses of the Company's cash resources. Shares may be used to satisfy obligations linked to share based payment awards for employees. Buy-backs are usually made by funding the Company's Employee Benefit Trusts (EBTs') which will then settle option exercises or hold shares for Restricted Share awards until they vest. During the Period the EBTs spent £2.5 million buying 1.2 million of the Company's shares at an average price of 212 pence. The EBTs delivered 1.8 million of shares to staff in respect of option exercises and Restricted Share vestings; in-line with the Company's policy, staff pay for these through deductions from the bonus paid. In December 2018 the EBTs allocated 0.5 million shares against awards of Restricted Shares made to staff and the Company awarded 0.5 million of share options to staff. At 31 March 2019 the EBTs held a total of 9.1 million shares of which 7.2 million were held for Restricted Shares. Further equity issuance may arise in respect of staff option exercises that have not been previously matched by share buy-backs, and, in 2021, conversion into Impax shares of Impax NH management's remaining 16.7% interest in Impax NH.

 

OUTLOOK

At the time of writing, market sentiment is overshadowed by uncertainty over global trade, particularly the relationship between China and the United States. Elsewhere, economic and financial market signals are mixed, and investor sentiment is fragile. Nevertheless, as investor interest in exposure to the sustainable economy continues to build, we are confident that Impax is well placed for further expansion.

 

Ian R Simm

4 June 2019

 

 

 

CONDENSED CONSOLIDATED income STATEMENT

For the six months ended 31 March 2019

 

 

 

Note

Six months ended
 31 March
2019
£000

Six months ended
31 March
2018
£000

Year ended
30 September 2018
£000

Revenue

 

33,794

25,680

65,683

Operating costs

 

(23,871)

(19,932)

(50,200)

Fair value (losses)/gains and other financial income/(expense)

5

(301)

28

(337)

Interest expense

 

(399)

(251)

(670)

Non-controlling interest

 

91

21

184

Change in third-party interests in consolidated funds

6

2

(30)

(40)

Profit before taxation

 

9,316

5,516

14,620

Taxation

7

(1,293)

(1,081)

(3,219)

Profit after taxation

 

8,023

4,435

11,401

 

 

 

 

 

Earnings per share

 

 

 

 

Basic

8

6.2 p

3.6 p

9.0 p

Diluted

8

6.1 p

3.4 p

8.9 p

 

 

CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

For the six months ended 31 March 2019

 

 

 

Six months ended
31 March
2019
£000

Six months ended
31 March
2018
Restated*
£000

Year ended
30 September 2018
£000

Profit for the period

8,023

4,435

11,401

Change in value of cash flow hedges

232

24

(74)

Tax on change in value of cash flow hedges

(44)

(5)

14

Exchange differences on translation of foreign operations

(46)

60

1,212

Total other comprehensive income

142

79

1,152

Total comprehensive income for the period
attributable to equity holders of the parent

8,165

4,514

12,553

 

*  Total other comprehensive income for the six month period has been restated to exclude the tax credit on long-term incentive schemes which is now being recognised within the transactions with owners section within the consolidated changes of equity as required by IFRSs.

All profit for the period is derived from continuing operations.

All amounts in other comprehensive income may be reclassified to income in the future.

Adjusted numbers are provided in Note 3.

 

 

CONDENSED CONSOLIDATED STATEMENT of financial position

AS AT 31 March 2019

 

 

 

Note

As at
31 March
2019
£000

As at
31 March
2018
£000

As at
30 September 2018
£000

Asset

 

 

 

 

Non-current assets

 

 

 

 

Goodwill

10

12,185

13,347

12,171

Intangible assets

10

24,343

24,775

25,565

Property, plant and equipment

 

1,784

1,849

1,836

Deferred tax assets

 

3,472

1,423

4,450

Total non-current assets

 

41,784

41,394

44,022

Current assets

 

 

 

 

Trade and other receivables

 

19,823

15,288

15,858

Investments

11

3,020

8,329

4,349

Current tax asset

 

869

2,927

890

Cash invested in money market funds and long-term deposit accounts

12

10,233

4,204

11,211

Cash and cash equivalents

12

6,131

5,434

15,529

Total current assets

 

40,076

36,182

47,837

Total assets

 

81,860

77,576

91,859

 

 

 

 

 

Equity and liabilities

 

 

 

 

Equity

 

 

 

 

Ordinary shares

 

1,304

1,304

1,304

Share premium

 

9,291

9,291

9,291

Exchange translation reserve

 

968

(138)

1,014

Hedging reserve

 

144

35

(44)

Retained earnings

 

42,934

36,399

41,054

Equity attributable to owners of the company

 

54,641

46,891

52,619

Non-controlling interests

 

1,012

914

898

Total equity

 

55,653

47,805

53,517

 

 

 

 

 

Current liabilities

 

 

 

 

Trade and other payables

 

15,755

17,971

24,755

Loans

13

3,316

3,078

3,326

Third-party interests in consolidated funds

 

-

77

87

Current tax liability

 

208

192

130

Total current liabilities

 

19,279

21,318

28,298

Non-current liabilities

 

 

 

 

Accruals

 

280

347

228

Loans

13

3,316

8,083

6,652

Deferred tax liability

 

3,332

23

3,164

Total non-current liabilities

 

6,928

8,453

10,044

Total liabilities

 

26,207

29,771

38,342

Total equity and liabilities

 

81,860

77,576

91,859

 

 

Condensed Consolidated Statement of Changes in Equity

For the six months ended 31 March 2019

 

 

 

Share
capital
£000

Share premium
£000

Exchange  translation reserve
£000

Hedging reserve
£000

Retained earnings
£000

Total
£000

As at 1 October 2017

1,277

4,093

(198)

16

30,456

35,644

Transactions with owners

 

 

 

 

 

 

Shares issued

 27

 5,198

 -

 -

 -

 5,225

Dividends paid

 -

 -

 -

 -

(2,752)

(2,752)

Cash received on option exercises

 -

 -

 -

 -

2,383

 2,383

Impax NH Management equity scheme - value assigned to pre-acquisition service

-

-

-

-

2,009

 2,009

Tax credit on long-term incentive schemes (restated*)

-

-

-

-

530

 530

Fair value of put option over non-controlling interest

 -

 -

 -

 -

(1,379)

(1,379)

Share based payment charges

 -

 -

 -

 -

716

716

Total transactions with owners (restated*)

 27

 5,198

 -

 -

 1,507

 6,732

Profit for the period

 -

 -

 -

 -

4,435

 4,435

Other comprehensive income

 

 

 

 

 

 

Change in value of cashflow hedges

 -

 -

 -

 24

 -

 24

Tax on change in value of cashflow hedges

 -

 -

 -

(5)

 -

(5)

Exchange differences on translation of foreign operations

 -

 -

 60

 -

 -

 60

Total other comprehensive income (restated*)

 -

 -

 60

 19

 -

 79

As at 31 March 2018

 1,304

 9,291

(138)

 35

 36,399

 46,891

Transactions with owners

 

 

 

 

 

 

Dividends paid

 -

 -

 -

 -

(4,634)

(4,634)

Acquisition of own shares

-

-

-

-

(2,534)

(2,534)

Cash received on option exercises

 -

 -

 -

 -

2,093

 2,093

Impax NH Management equity scheme - value assigned to pre-acquisition service

 -

 -

 -

 -

(92)

(92)

Tax credit on long-term incentive schemes

-

-

-

-

1,822

 1,822

Fair value of put option over non-controlling interest

 -

 -

 -

 -

(72)

(72)

Share based payment charge

 -

 -

 -

 -

1,106

1,106

Total transactions with owners

 -

 -

 -

 -

(2,311)

(2,311)

Profit for the period

 -

 -

 -

 -

6,966

 6,966

Other comprehensive income

 

 

 

 

 

 

Cashflow hedge

 -

 -

 -

(98)

 -

(98)

Tax on cash flow hedge

 -

 -

 -

19

-

 19

Exchange differences on translation of foreign operations

 -

 -

1,152

 -

 -

 1,152

Total other comprehensive income

 -

 -

 1,152

(79)

 -

 1,073

As at 30 September 2018

 1,304

 9,291

 1,014

(44)

 41,054

 52,619

Transactions with owners

 

 

 

 

 

 

Dividends paid

 -

 -

 -

 -

(3,864)

(3,864)

Acquisition of own shares

 -

 -

 -

 -

(2,502)

(2,502)

Cash received on option exercises

 -

 -

 -

 -

 100

 100

Tax charge on long-term incentive schemes

 -

 -

 -

 -

(250)

(250)

Fair value of put option over non-controlling interest

 -

 -

 -

 -

(293)

(293)

Share based payment charge

 -

 -

 -

 -

666

 666

Total transactions with owners

 -

 -

 -

 -

(6,143)

(6,143)

Profit for the period

 -

 -

 -

 -

8,023

 8,023

Other comprehensive income

 

 

 

 

 

 

Cashflow hedge

 -

 -

 -

232

 -

 232

Tax on cashflow hedge

 -

 -

 -

(44)

 -

(44)

Exchange differences on translation of foreign operations

 -

 -

(46)

 -

 -

(46)

Total other comprehensive income

 -

 -

(46)

 188

 -

 142

As at 31 March 2019

 1,304

 9,291

 968

 144

 42,934

 54,641

 

*  See consolidated statement of comprehensive income for details of the restatement

 

Condensed Consolidated Statement of Cash Flows

For the six months ended 31 March 2019

 

 

 

Note

Six months ended
31 March
2019
£000

Six months ended
31 March
2018
£000 Restated*

Year ended
30 September 2018
£000

 

 

 

 

 

Operating activities

 

 

 

 

Cash generated from operations

17

825

3,634

23,436

Corporation tax (paid)/refunded

 

(306)

(209)

1,583

Net cash generated from operating activities

 

519

3,425*

25,019

 

 

 

 

 

Investing activities:

 

 

 

 

Acquisition of new subsidiary, net of cash acquired

15

-

(24,459)

(23,893)

Deconsolidation of investment fund

 

(67)

(255)

(255)

Net acquisition of property plant and equipment and intangible assets

 

(128)

(1,480)

(1,690)

Net (investments into)/redemptions made by Impax in unconsolidated investment funds

 

(1,041)

67

3,938

Net investments disposals from consolidated Impax funds

 

-

-

932

Settlement of investment related hedges

 

74

140

(987)

Decrease/(increase) in cash held by money market funds
and long-term deposit accounts

 

1,045

3,576

(3,431)

Investment income received

 

151

154

279

Net cash generated from/(used by) investment activities

 

34

(22,257)

(25,107)

 

 

 

 

 

Financing activities:

 

 

 

 

Proceeds from bank borrowings

13

-

17,616

17,616

Repayment of bank borrowings

13

(3,337)

(6,183)

(8,779)

Interest paid on bank borrowings

 

(310)

(71)

(464)

Dividends paid

9

(3,864)

(2,752)

(7,386)

 Acquisition of own shares

 

(2,502)

-

(2,534)

Cash received on exercise of Impax share options

 

100

2,383

4,477

Redemptions/(Investments) by third party investors into consolidated funds

 

(39)

20

17

Net cash (used by)/generated from financing activities

 

(9,952)

11,013

2,947

Net (decrease)/increase in cash and cash equivalents

 

(9,399)

(7,819)*

2,859

 

 

 

 

 

Cash and cash equivalents at the beginning of the period

 

15,529

12,932

12,932

Effect of foreign exchange rate changes

 

1

321

(262)

Cash and cash equivalents at the end of the period

12

6,131

5,434

15,529

 

*  £946,000 of cash received into RPA accounts (see note 12) previously shown as an increase in cash and cash equivalents at the foot of the cash flow statement has now been reclassified to an increase in cash generated from operations. There is no effect on the opening or closing cash for the period.

 

 

Notes to the Condensed Consolidated Interim Financial Statements

For the six months ended 31 March 2019

 

1   Basis of preparation

This interim report is unaudited and does not constitute statutory accounts within the meaning of Section 435 of the Companies Act 2006. These condensed consolidated interim financial statements have been prepared in accordance with IAS 34 'Interim Financial Reporting' as adopted by the EU and the AIM rules. They do not include all of the information required for full annual financial statements, and should be read in conjunction with the consolidated financial statements of the Group for the year ended 30 September 2018.

The comparative figures for the financial year ended 30 September 2018 are not the Company's statutory accounts for that financial year. Those accounts, prepared in accordance with IFRSs as adopted by the EU, have been reported on by the Company's auditors and delivered to Companies House. The report of the auditors was (i) unqualified, (ii) did not include a reference to matters to which the auditors drew attention by way of emphasis without qualifying their report, and (iii) did not contain a statement under Section 498 (2) or (3) of the Companies Act 2006. Copies of these accounts are available upon request from the Company's registered office at 30 Panton St, London, SW1Y 4AJ or at the Company's website: www.impaxam.com.

The Group has considerable financial resources and a broad range of products. As a consequence, the Directors believe the Group is well placed to manage its business risks in the context of the current economic outlook. The Directors therefore have a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future and have continued to adopt the going concern basis in preparing these interim financial statements.

Accounting policies

The accounting policies applied by the Group in these condensed consolidated interim financial statements are the same as those applied by the Group in its consolidated financial statements for the year ended 30 September 2018. The Group has applied the following accounting standards for the first time for the reporting period beginning on 1 October 2018.
- IFRS 9 Financial instruments; and
- IFRS 15 Revenue from Contracts with Customers.

Neither of these standards has had a significant impact on the Group's financial statements.

New and forthcoming accounting standards applicable to the Group

IFRS 16 Leases will become applicable from 1 October 2019 and the first annual report published in accordance with IFRS 16 will be the 30 September 2020 report. We are currently assessing the impact of adopting this standard.

No other new standards or interpretations issued or not yet effective are expected to have an impact on the Group's condensed consolidated financial statements.

 

2   Estimates

 

The preparation of interim financial statements requires management to make judgements, estimates and assumptions that affect the application of accounting policies and the reported amounts of assets and liabilities, income and expense. Actual results may differ from these estimates.

In preparing these condensed consolidated interim financial statements, the significant judgements made by management in applying the Group's accounting policies and the key sources of estimation uncertainty were: i) judgements and estimates made in the valuation of acquired management contracts (see Note 15) and in the determining of their useful economic lives; ii) estimating the amount of contingent consideration that will be paid for the acquisition of Pax World Management LLC (see Note 15); iii) judgements and estimates made in determining the valuation of unlisted current asset investments (see Note 11) and iv) estimating the size of share based payments.

 

3    ADJUSTED EARNINGS AND PROFIT

 

The reported operating profit, profit before tax and earnings per share in the current and prior periods presented are substantially affected by non-recurring acquisition costs, business combination effects and other items. The Directors have therefore decided to report an adjusted operating profit, adjusted profit before tax and adjusted earnings per share which exclude these items in order to enable comparison with peers and provide consistent measures of performance over time. A reconciliation of the adjusted amounts to the IFRS reported amounts is shown below.

 

Six months ended 31 March 2019

Reported
IFRS
£000

Adjustments

Adjusted
£000

Non-recurring acquisition costs
£000

Business combination effects
£000

Other
£000

Revenue

33,794

 

 

 

33,794

Operating costs

(23,871)

 

 

 

(26,081)

Amortisation of intangibles arising on acquisition

 

 

1,247

 

 

Credit from contingent consideration adjustment

 

 

(3,543)

 

 

Acquisition equity incentive scheme charges

 

 

44

 

 

Mark to market charge on equity awards

 

 

 

42

 

Operating Profit

9,923

 

(2,252)

42

7,713

Fair value (losses)/gains on investments and other financial (expense)/income

(301)

 

208

(110)

(203)

Interest expense

(399)

 

 

 

(399)

Non controlling interest

91

 

 

 

91

Change in third-party consolidated funds

2

 

 

 

2

Profit before taxation

9,316

 

(2,044)

(68)

7,204

Taxation

(1,293)

 

 

 

(1,280)

Tax credit on adjustments

 

 

 

13

 

Profit after taxation

8,023

 

(421)

(55)

5,924

Diluted earnings per share

6.13p

 

(1.65)p

(0.04)p

4.43p

 

 

Six months ended 31 March 2018

Reported
IFRS
£000

Adjustments

Adjusted
£000

Non-recurring acquisition costs
£000

Business combination effects
£000

Other
£000

Revenue

25,680

 

 

 

25,680

Operating costs

(19,932)

 

 

 

(17,952)

Acquisition costs

 

847

 

 

 

Amortisation of intangibles arising on acquisition

 

 

484

 

 

Acquisition equity incentive scheme charges

 

 

97

 

 

Mark to market charge on equity awards

 

 

 

552

 

Operating profit

5,748

847

581

552

7,728

Fair value (losses)/gains on investments and other financial (expense)/income

28

 

 

(105)

(77)

Interest expense

(251)

 

 

 

(251)

Non-controlling interest

21

 

 

 

21

Change in third-party consolidated funds

(30)

 

 

 

(30)

Profit before taxation

5,516

847

581

447

7,391

Taxation

(1,081)

 

 

 

(1,286)

Tax credit on adjustments

 

(120)

 

(85)

 

Profit after taxation

4,435

727

581

362

6,105

Diluted earnings per share

3.45p

0.60p

0.48p

0.30p

4.83p

 

The adjusted diluted earnings per share is calculated using the adjusted profit after taxation shown above with a further adjustment for profit attributable to owners of restricted shares of £439,000 (see Note 8). The diluted number of shares is the same as used for the IFRS calculation of earnings per share (see Note 8).

The same adjustments have been made, where relevant, for the year ended 30 September 2018 to give adjusted operating profit of £19,987,000, adjusted profit before tax of £19,208,000 and adjusted diluted earnings per share of 12.4 pence.

Contingent consideration adjustment

We are required to review and adjust our estimate of the contingent consideration payable in respect of the Impax NH acquisition (see Note 15). Any adjustment is recorded through income but is excluded from adjusted profit.

 

Mark to market charge on equity incentive awards

The group has awarded employees in prior years and the current period options over the Group's shares, some of which are either unvested or unexercised at the balance sheet date. The Group has also made awards of restricted shares ('RSS awards') the majority of which have not vested at the balance sheet date. Employer's National Insurance Contributions ('NIC') are payable on the option awards when they are exercised and on the RSS awards when they vest, based on the valuation of the underlying shares at that point. The Group does however receive a corporation tax credit equal to the value of the awards at the date they are exercised (options) or vest (RSS awards). A charge is accrued for the NIC within IFRS operating profit based on the share price at the balance sheet date. Similarly a credit for the corporation tax is accrued within the IFRS tax charge and where the corporation tax credit is larger than the share based payments within equity. Additional retention payments are made to holders of vested legacy LTIP awards ('LTIP') when they are exercised. The payment will be equal to the corporation tax benefit the Group receives on the exercise of the options minus the amount of NIC payable on exercise. The charge is accrued based on the share price at the balance sheet date.

These two charges vary based on the Group's share price (together referred to as mark to market charge on equity schemes) and are not linked to the operating performance of the Group. They are therefore eliminated when reporting adjusted profit.

 

4   Segment Information

The Group's reportable segments have been identified in accordance with the way in which the Group is structured and managed. IFRS 8 Operating Segments requires that the information presented in the financial statements is based on information provided to the 'Chief Operating Decision Maker'. The Chief Operating Decision Maker for the Group is the Chief Executive.

The Group's reportable segments are as follows:

Impax LN

Impax LN represent the Group's business prior to the acquisition of Impax Asset Management LLC. It manages and advises listed equity and real asset funds and accounts.

Impax NH

Following acquisition Impax Asset Management LLC has operated as a separate segment managing the Pax World Funds and is now referred to as Impax NH.

The following tables present revenue and profit information for the Group's operating segments.

Six months ended 31 March 2019

 

 

Impax LN
£000

Impax NH
£000

Adjustments
£000

Consolidated
£000

Revenue

 

 

 

 

External customers

22,282

11,512

-

33,794

Inter-segment

1,042

-

(1,042)

-

Total revenue

23,324

11,512

(1,042)

33,794

Segment profit - adjusted operating profit

6,929

784

-

7,713

 

Six months ended 31 March 2018

 

Impax LN
£000

Impax NH
£000

Adjustments
£000

Consolidated
£000

Revenue

 

 

 

 

External customers

20,840

4,840

-

25,680

Inter-segment

376

-

(376)

-

Total revenue

21,216

4,840

(376)

25,680

Segment profit - adjusted operating profit

6,764

964

-

7,728

 

Twelve months ended 30 September 2018

 

Impax LN
£000

Impax NH
£000

Adjustments
£000

Consolidated
£000

Revenue

 

 

 

 

External customers

48,262

17,421

-

65,683

Inter-segment

1459

-

(1,459)

-

Total revenue

49,721

17,421

(1,459)

65,683

Segment profit - adjusted operating profit

17,716

2,271

-

19,987

 

Segment profit is stated at the adjusted operating profit level as shown in Note 3.     

 

5   Fair value gains/(losses) and other financial income/expense

Fair value gains/(losses) include those arising on revaluation of listed and unlisted investments held by the Group including those held by the Group's consolidated funds (see Note 11) and any gains or losses arising on related hedge instruments held by the Group. Other financial income includes foreign exchange gains or losses.

 

6   Change in third party interest in consolidated funds

This charge removes the fair value gains or losses, other operating costs and investment income recorded in the Group's consolidated funds (see Note 11) which are attributable to third party investors in the funds.

 

7   Taxation

The tax rate for the period is higher than the standard rate of corporation tax in the UK for the period (19 per cent). The differences are explained below:

 

Six months ended
31 March
2019
£000

Six months ended
31 March
2018
£000

Year ended
30 September 2018
£000

Profit before tax

9,316

5,516

14,620

Tax charge at 19 per cent

1,770

1,048

2,778

Effects of:

 

 

 

Non-deductible expenses and charges

54

6

248

Non-taxable income

(673)

-

(24)

Adjustment in respect of historical tax charges

-

(99)

98

Change in tax rates

-

60

-

Effect of higher tax rates in foreign jurisdictions

142

66

240

Tax deductibility of goodwill

-

-

(66)

Utilisation of tax losses brought forward and not recognised

-

-

(55)

Total income tax expense

1,293

1,081

3,219

 

8   Earnings per share

 

Earnings for the period
£'000

Shares
'000

Earnings
per share

Six months ended 31 March 2019

 

 

 

Basic

7,584

122,680

6.2p

Diluted

7,584

123,745

6.1p

 

 

 

 

Six months ended 31 March 2018

 

 

 

Basic

4,148

116,612

3.6p

Diluted

4,148

120,374

3.4p

 

 

 

 

Year ended 30 September 2018

 

 

 

Basic

10,663

118,758

9.0p

Diluted

10,663

119,581

8.9p

 

Earnings are reduced by £439,000 for the six months ending 31 March 2019 (31 March 2018: £287,000, 30 September 2018: £738,000) for basic and diluted earnings per shares to reflect the profit attributable to holders of restricted shares, which are treated as contingently returnable shares.

The weighted average number of shares is calculated as shown in the table below.

 

Six months ended
31 March
2019
'000

Six months ended
31 March
2018
'000

Year ended 30 September 2018
'000

Weighted average issued share capital

130,415

128,860

129,612

Less own shares held not allocated to vested LTIP options

(7,735)

(12,248)

(10,854)

Weighted average number of ordinary shares used in the calculation of basic EPS

122,680

116,612

118,758

Additional dilutive shares re share options

2,850

5,941

2,550

Adjustment to reflect option exercise proceeds and future service from employees receiving awards/shares

(1,785)

(2,179)

(1,727)

Weighted average number of ordinary shares used in the calculation of diluted earnings per share

123,745

120,374

119,581

 

The basic earnings per share for all periods shown includes vested LTIP options on the basis that these have an inconsequential exercise price (1 pence or 0 pence). As described in Note 15 the Group has an agreement with Management Shareholders of Impax LLC under which it can acquire their shares in Impax NH in exchange for Group shares. This arrangement is not dilutive.

Restricted stock units were also issued to Impax NH staff and management which have a three year vesting period from the date of acquisition and a further two year restriction on the holders ability to sell the vested awards. The value of the Impax shares received is determined by reference to the Impax NH assets under management at the vesting date. These awards are currently out of the money and accordingly the scheme is not dilutive.

 

9   Dividends

On 2 March 2019, at the Company's Annual General Meeting, payment of a 3.0 pence per share final dividend for the year ended 30 September 2018 (2017: 2.2 pence per share) was approved. Combined with an interim payment of 1.1 pence and the special dividend paid alongside the interim dividend of 2.6 pence this gave total dividends for the year ended 30 September 2018 of 6.7 pence. The Trustee of the Impax Employee Benefit Trusts waived the Trusts' rights to part of the final dividend, leading to a total final dividend payment of £3,863,544. This was paid on 15 March 2019.

The Board has declared an interim dividend for the period of 1.5 pence per ordinary share (2018: 1.1 pence). This dividend will be paid on 19 July 2019 to ordinary shareholders on the register at close of business on 14 June 2019.

The Board has not declared a special dividend for the period (2018: 2.6 pence for the year).

 

10 Goodwill and Intangible assets

The goodwill and intangible assets held by the Group primarily relate to the acquisition of Impax NH, see Note 15 for further information.

Goodwill

 

£000

Cost

 

At 30 September 2017

1,681

Additions

11,876

Foreign exchange movement

(210)

At 31 March 2018

13,347

Adjustments

(1,945)

Impairment

(52)

Foreign exchange movement

821

At 30 September 2018

12,171

Foreign exchange movement

14

At 31 March 2019

12,185

 

There were no brought forward impairment losses at 30 September 2017 or impairment charges during the period.

 

Intangible assets

 

Intangible assets - management contracts
£000

Intangible assets - software
£000

Total
£000

Cost

 

 

 

At 30 September 2017

112

342

454

Additions

25,669

35

25,704

Foreign exchange movement

(449)

-

(449)

At 31 March 2018

25,332

377

25,709

Additions

-

41

41

Foreign exchange movement

2,049

-

2,049

At 30 September 2018

27,381

418

27,799

Additions

-

36

36

Foreign exchange movement

(138)

-

(138)

At 31 March 2019

27,243

454

27,697

Accumulated amortisation and impairment

 

 

 

At 30 September 2017

112

325

437

Amortisation

491

6

497

Foreign exchange movement

-

-

-

At 31 March 2018

603

331

934

Amortisation

1,231

13

1,244

Foreign exchange movement

56

-

56

At 30 September 2018

1,890

344

2,234

Amortisation

1,247

20

1,267

Foreign exchange movement

(147)

-

(147)

At 31 March 2019

2,990

364

3,354

 

 

 

 

Net book value

 

 

 

At 31 March 2019

24,253

90

24,343

At 30 September 2018

25,491

74

25,565

At 31 March 2018

24,729

46

24,775

 

11 Current asset investments

The Group will from time to time facilitate the establishment of funds for which it is the investment manager. The Group may invest seed capital in these funds in order to provide initial scale and to facilitate the marketing of the fund to third party investors. Where the Group has control of the fund it is consolidated and its underlying investments are shown in listed investments in the table below. Where the investments are not consolidated they are shown in unlisted investments in the table below. The Group also invests in private equity funds it manages, these investments are shown in unlisted investments in the table below.

 

Unlisted investments
£000

Listed investments
£000

Total
£000

At 30 September 2017

1,067

11,946

13,013

Additions

16

-

16

Fair value movements

(135)

119

(16)

Deconsolidation of IEL fund

4,670

(9,271)

(4,601)

Repayments/disposals

(83)

-

(83)

At 31 March 2018

5,535

2,794

8,329

Additions

1,509

811

2,320

Fair value movements

502

321

823

Repayments/disposals

(5,380)

(1,743)

(7,123)

At 30 September 2018

2,166

2,183

4,349

Additions

1,041

-

1,041

Fair value movements

(187)

(60)

(247)

Deconsolidation of IGEO fund

2,073

(2,123)

(50)

Repayments/disposals

(2,073)

-

(2,073)

At 31 March 2019

3,020

-

3,020

 

Listed investments

Impax Global Equity Opportunities fund ('IGEO') (consolidated)

On 23 January 2015 the Group launched the IGEO Fund and invested from its own resources £2 million into the fund. IGEO invests in listed equities using the Group's Global Opportunities strategy. The Group redeemed £0.93 million of its investment in the year ended 30 September 2018 and the balance of the investment being £2.07 million in March 2019. The Group's investment represented more than 50 per cent of IGEO's NAV up to the redemption date and has been consolidated throughout this period with its underlying investments included in listed investments in the table above.

The investments held by IGEO were revalued to market value using quoted market prices.

Unlisted investments

Pax Global Opportunities Fund (not consolidated)

On 27 June 2018 the Group launched the Pax Global Opportunities Fund ('Pax GO') and invested US$2 million from its own resources into the fund. Pax GO invests in listed equities using the Group's Global Opportunities Strategy. The level of the Group's investment has meant that consolidation is not required and accordingly the investment is recorded as an unlisted investment.

Impax Environmental Leaders fund ('IEL') (not consolidated)

On 11 January 2016 the Group launched the Impax Environmental Leaders (Ireland) Fund ('IEL') and invested from its own resources £3 million in the fund. IEL invests in listed equities using the Group's Leaders Strategy. The Group consolidated this fund for the period from the date of its initial investment to 30 September 2017 with its underlying investments included in listed investment in the table above. During the prior period investments made by third parties meant that consolidation was no longer required and the fund was deconsolidated with the investment shown in Unlisted investments. The Group fully redeemed its investment in the Fund on 28 September 2018 for £4.87 million.       

Private equity funds (not consolidated)

The Group has a 1.12 per cent partnership share in Impax New Energy Investors III LP, a private equity partnership managed by the Group. To date the Group has invested a total of €0.99 million into the partnership. The Group has a commitment to invest up to a further €3.01 million into this partnership.

The Group has a 1.14 per cent partnership share in Impax New Energy Investors II LP, a private equity partnership managed by the Group. To date the Group has invested a total of €2.20 million into the partnership and received distributions of €2.96 million following sales of investments by the partnership. The remaining investment is included at the Board's assessment of its fair value, being £0.11 million at 31 March 2019, which is determined by valuing the underlying investments. The principal valuation techniques used are price of recent investment and market bids. The Group has a commitment to invest up to a further €0.55 million into this partnership.

The Group has a 3.76 per cent partnership share of Impax New Energy Investors LP, a private equity partnership managed by the Group. At the balance sheet date the partnership had fully divested of its investments and the carrying value of the Group's investment in the partnership was nil. The partnership is however part of a group of investors who have claimed compensation from the Spanish government for losses on investments it previously owned, incurred following significant retroactive reforms to the Spanish energy markets. The claim is currently being heard by the European Court of Arbitration. In the event that the claim is successful the Group will receive its share of the compensation.

 

12 Cash reserves

Cash and cash equivalents under IFRS does not include deposits in money market funds or cash held in deposits with an original maturity of more than three months. However the Group considers its total cash reserves to include these amounts. Cash held by consolidated funds is not considered to be available to the Group so is not included in cash reserves. Cash held in Research Payment Accounts ('RPAs') is collected from funds managed by the Group and can only be used towards the cost of researching stocks. A liability of an equal amount is included in trade and other payables. This cash is also excluded from cash reserves. A reconciliation is shown overleaf:

 

 

31 March
2019
£000

31 March
2018
£000

30 September
2018
£000

Cash and cash equivalents

6,131

5,434

15,529

Cash held in money market funds and long-term deposit accounts

10,233

4,204

11,211

Less: cash held in RPAs

(1,426)

(946)

(2,074)

        : cash and cash equivalents held by consolidated funds

-

(101)

(67)

Total cash reserves

14,938

8,591

24,599

 

13 Loans

To part fund the acquisition of Impax NH the Group signed a debt facility with RBS. The facility consists of a US$13 million term loan repayable annually over a 3 year term and a US$13 million revolving credit facility ('RCF') with a 5 year tenor. The term loan incurs interest at US LIBOR plus 2.9 per cent and the revolving credit facility at US LIBOR plus 3.3%. On completion of the acquisition the Group drew down the term loan in full and US$12 million of the revolving credit facility. At 31 March 2019 the revolving credit facility was repaid in full and $4.33m of the term loan leaving US$8.66 million of debt outstanding.

 

14 Share capital and own shares

 

31 March
2019

31 March
2018

30 September 2018

Issued and fully paid ordinary shares of 1 pence each

 

 

 

Number

130,415,087

130,415,087

130,415,087

£000s

1,304

1,304

1,304

 

 

31 March
2019

31 March
2018

30 September 2018

Own shares

 

 

 

Number

9,075,766

13,672,081

9,742,146

£000s

6,793

4,339

5,420

 

Own shares represents a portion of those held in Impax's Employee Benefit Trusts. 1.2 million shares were acquired in the six months ended 31 March 2019, (period ended 31 March 2018: nil). 1.8 million shares were awarded to option holders on exercise of options or on lapse of restrictions on shares (period ended 31 March 2018: 5.3 million). As at 31 March 2019 there were a total of 4.6 million options outstanding of the Group's shares of which 2.8 million were exercisable. As at 31 March 2019 employees also held 7.2 million Restricted Shares over which the restrictions lapse from January 2020 through to December 2023. These shares are held in trust and are included in own shares above.

 

15 Acquisition of Pax World Management LLC

On 18 January 2018, the Group completed the acquisition of Pax World Management LLC ('Pax'). Pax is a recognised leader in the field of sustainable investing in the United States. Based in Portsmouth, New Hampshire, Pax manages eleven mutual funds and at the date of acquisition had assets under management of £3.5 billion. This business combination creates scale for the Group's operations in North America and broadens the range of investment strategies the Group offers clients, including fixed income and passive equity.

Following completion of the acquisition Pax was renamed Impax Asset Management LLC ('Impax NH').

The Group has initially acquired an ca. 83.3 per cent interest of Pax's share capital from the selling shareholders (the 'Selling Shareholders') in exchange for cash payable on the acquisition date of $36.2 million, 2,665,989 Impax shares and up to $31.3m of contingent payments ('Contingent Consideration'). Impax NH's management and staff shareholders (the 'Management Shareholders'), representing the remaining ca.16.7 per cent of Pax's issued share capital will retain their shareholding until 2021 when if either Impax or the Management Shareholders exercise a put and call option arrangement, the Group would acquire their entire holding for US$8.3 million and up to $6.3 million of Contingent Consideration. This would be paid in 2021 in Impax equity and/or cash, as the Group elects.

The cash payable on acquisition was determined as US$38.1 million less US$1.9 million of balance sheet adjustments for working capital and transaction costs.

The number of Group shares issued to the Selling Shareholders was determined using an agreed value of US$6.1 million, the 20 day average of the Group's share price to 12 January 2018 being 170.19 pence and a US$/GBP exchange rate of 0.7403. The fair value of these shares used to determine the total consideration in the table below was determined to be 196 pence, using the Group's mid-market closing share price on 17 January 2018.

The Contingent Consideration will be determined based on Impax NH's average AUM as at 30 June 2020, 30 September 2020 and 31 December 2020 and will rise linearly from zero, if Impax NH's average AUM is not more than US$5.5 billion, to US$37.5 million for the entire share capital of Impax NH, if Impax NH's average AUM is $8 billion or above. To the extent that Impax NH has achieved these performance targets, based on Impax NH's average AUM as at 31 December 2018, 31 March 2019 and 30 June 2019, up to $8.3 million of Contingent Consideration will become payable to the Selling Shareholders within 45 days of 30 June 2019. The fair value of the Contingent Consideration payable to the Selling Shareholders was estimated as $4.2 million at the acquisition date (subsequently reduced - see below). As with the initial consideration, settlement of any Contingent Consideration payable to Impax NH's Management Shareholders is expected to be made in 2021 in the Group's ordinary shares at the share price prevailing at the time and or in cash if Impax so elects.

Prior to the acquisition, Management Shareholders acquired their stake in Impax NH using loans provided by Impax NH with part of the distributions made by Impax NH being used to repay the loan and interest. The shares were subject to certain restrictions linked to the employment of the individual. On acquisition the Group agreed to extend the period of these loans until 2021 in line with the put and call arrangements over the shares and have retained certain of the employment restrictions on the shares. The original arrangement is considered to be a share based payment for the individuals which has been replaced by a new share based payment in the Group's shares. The fair value of this equity scheme assigned to pre-acquisition service is included as part of the consideration on acquisition and a charge for the new share based payment award is included in the income statement over the period from acquisition to 31 December 2020, when the employment restriction over the shares ends.

The acquisition has been accounted for using the acquisition method.

An analysis of the consideration paid, the recognised amounts of assets acquired and liabilities assumed and the resulting goodwill is provided below.

Consideration

£000

Cash and cash equivalents

26,209

Group shares - 2,665,989 shares

5,225

Contingent Consideration

3,039

Valuation of management equity scheme assigned to pre-acquisition service

1,806

 

36,279

 

 

Recognised amounts of identifiable assets acquired and liabilities assumed

£000

Assets

 

Property, plant and equipment

67

Intangible assets - management contracts

25,669

Cash

2,316

Trade receivables

3,041

Total assets

31,093

Liabilities

 

Trade and other payables

(3,763)

Total liabilities

(3,763)

Total identifiable net assets at fair value

27,330

Non-controlling interest

(982)

Goodwill arising on acquisition

9,931

Total

36,279

 

We have reviewed the estimate of the contingent consideration payable at 31 March 2019 and concluded that it should be reduced to £nil. This adjustment is recorded through the income statement.

 

16 Related party transactions

Private Equity Funds managed by the Group, entities controlled by these funds and the Impax Global Resource Optimization Fund LP are related parties of the Group by virtue of subsidiaries being the General Partners to these funds. The Group earns management fees from these entities.

BNP Paribas Asset Management Holdings is a related party of the Group by virtue of owning a 24.5 per cent equity holding. The Group sub-manages certain funds for BNP for which it earns fees. Other funds managed by subsidiaries of the Group are also related parties by virtue of its management contracts.

Revenue earned from related parties of the Group is as shown in the table below.

 

Six months ended
31 March
2019
£000

Six months ended
31 March
2018
£000

Year ended 30 September
2018
£000

Revenue

 33,624

 25,610

 65,513

 

Investments in related parties of the Group and trade and other receivables due from related parties are as shown in the table below

 

 

31 March
2019
£000

31 March
2018
£000

30 September 2018
£000

Current asset investments

 1,139

 5,535

 97

Trade and other receivables

 16,477

13,825

 12,200

 

17 Reconciliation of CASH GENERATED FROM OPERATIONS

This note should be read in conjunction with the cashflow statement. It provides a reconciliation of how profit before tax, which is based on IFRS accounting rules, translates to cashflows.

 

Six months ended
31 March
2019
£000

Six months ended
31 March
2018
£000

Year ended
30 September 2018
£000

Profit before taxation

9,316

5,516

14,620

Adjustments for:

 

 

 

Depreciation and amortisation

1,411

614

2,051

Fair value (losses)/gains and other financial income/expense

301

(28)

337

Contingent consideration adjustment

(3,543)

-

-

Share-based payment charges

666

716

1,822

Non controlling interest

(91)

(21)

(184)

Interest expense

399

251

670

Change in third party interests in consolidated funds

(2)

30

40

Operating cash flows before movement in working capital

8,457

7,078

19,356

(Increase) in receivables

(1,784)

(162)

(2,011)

(Decrease)/Increase in payables

(5,848)

(3,282)

6,091

Cash generated from operations

825

3,634

23,436

 

Certain adjustments and reclassifications have been made to the reconciliation shown for the period to 31 March 2018 to conform with the presentation for the current period.

 

18 Group risks

The Group's principal risks remain as detailed within the Directors' report of the Group's 2018 Strategic Report.

 

19 ACQUISITION OF MINORITY INTEREST IN PAX ELlEVATE MANAGEMENT LLC

Impax Asset Management LLC, the majority owner (51%) of Pax Ellevate Management LLC ('Pax Ellevate'), has agreed to purchase the minority (49%) currently held by Ellevate Management LLC ('Ellevate') for consideration of £1.81 million (£0.75 million after settlement of amounts due to Impax by Ellevate). The acquisition subject to approval by the shareholders of the fund managed by Pax Ellevate is expected to close in August 2019.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR FIMRTMBIMBPL
Close


London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.

 


Interim results to 31 March 2019 - RNS